Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This Year
February 26, 2016 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Feb. 26, 2016 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased to announce that the Company’s portfolio investment company, Kannalife Sciences, Inc. (“Kannalife”),...
Medical Marijuana, Inc's Portfolio Investment Company Kannalife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents
August 14, 2015 09:00 ET
|
Medical Marijuana Inc
SAN DIEGO, Aug. 14, 2015 (GLOBE NEWSWIRE) -- Medical Marijuana, Inc. portfolio investment company Kannalife Sciences, Inc. has announced the publication of its global WIPO/PCT Patent WO2015/106108A2...
Kannalife Sciences Discusses Orphan Drug Opportunity for KLS-13019
August 11, 2015 13:50 ET
|
KannaLife Sciences, Inc.
NEW YORK, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Kannalife Sciences, Inc., a Phyto-Medical Company, describes orphan drug opportunity for KLS-13019, a Novel Functionalized 1,3-Benzene Diol for the...
KannaLife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents
August 06, 2015 13:54 ET
|
KannaLife Sciences, Inc.
NEW YORK, Aug. 6, 2015 (GLOBE NEWSWIRE) -- KannaLife Sciences, Inc., a Phyto-Medical Company, announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – 'Novel Functionalized...